Business Description
Baudax Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US07160F4046
Share Class Description:
BXRXQ: Ordinary SharesDescription
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs and a dedicated reversal agent.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.19 | |||||
| 9-Day RSI | 37.81 | |||||
| 14-Day RSI | 36.34 | |||||
| 6-1 Month Momentum % | -98.77 | |||||
| 12-1 Month Momentum % | -99.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -1127.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.22 | |||||
| EV-to-EBITDA | -0.24 | |||||
| EV-to-Revenue | 6.1 | |||||
| EV-to-Forward-Revenue | 0.29 | |||||
| Earnings Yield (Greenblatt) % | -454.55 | |||||
| FCF Yield % | 8.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BXRXQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baudax Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.269 | ||
| EPS (TTM) ($) | -9.23 | ||
| Beta | 1.96 | ||
| Volatility % | 103.05 | ||
| 14-Day RSI | 36.34 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -99.76 | ||
| 52-Week Range ($) | 0.0001 - 0.056 | ||
| Shares Outstanding (Mil) | 43.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baudax Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baudax Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baudax Bio Inc Frequently Asked Questions
What is Baudax Bio Inc(BXRXQ)'s stock price today?
The current price of BXRXQ is $0.00. The 52 week high of BXRXQ is $0.06 and 52 week low is $0.00.
When is next earnings date of Baudax Bio Inc(BXRXQ)?
The next earnings date of Baudax Bio Inc(BXRXQ) is 2024-12-04 Est..
Does Baudax Bio Inc(BXRXQ) pay dividends? If so, how much?
Baudax Bio Inc(BXRXQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers